Skip to main content

Inside the world of cell therapies

While uptake has been limited, cell therapy’s impact in cancer care is growing, and biotech companies have continued to invest in ways to improve it, such as through “off-the-shelf” options or by using different types of immune cells. Explore the current market for cancer cell therapies and what biotechs are working on next.

included in this trendline
  • Cell and gene therapy manufacturing: the next generation of startups
  • A new startup adds $255M as investors pour cash into cell therapy production
  • J&J sees trial data supporting earlier CAR-T use in multiple myeloma
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.